Tenax Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$11.66

+0.01 (+0.09%)

As of May 16, 2:15 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +185.8% upside

Low Target $30.09

Average Target $33.33

High Target $42.13

Current Price $11.66

Current
$11.66

Target
$33.33

$30.09 $33.33 avg $42.13

Scenario Analysis

Bear Case

$30.09

158.1%

Low target

Base Case

$33.33

+185.8%

Avg target

Bull Case

$42.13

+261.3%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$18.38

-36.6% from high

52-Week Low

$5.34

+118.4% from low

Target vs 52W High

$33.33

+81.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%